drugset / Trial / NCT01557010
Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate efficacy, safety of administered DWP05195 in Postherpetic Neuralgia.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-11
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWP05195 | Small molecule | 100 mg | Oral |
| Subject | DWP05195 | Small molecule | 200 mg | Oral |
| Subject | DWP05195 | Small molecule | 300 mg | Oral |